Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy

The Khorana score is recommended for guiding primary venous thromboembolism (VTE) prophylaxis in cancer patients, but its clinical utility overall and across cancer types remains debatable. Also, some previous validation studies have ignored the competing risk of death, hereby potentially overestima...

Descripción completa

Detalles Bibliográficos
Autores principales: Overvad, Thure Filskov, Ording, Anne Gulbech, Nielsen, Peter Brønnum, Skjøth, Flemming, Albertsen, Ida Ehlers, Noble, Simon, Vistisen, Anders Krog, Gade, Inger Lise, Severinsen, Marianne Tang, Piazza, Gregory, Larsen, Torben Bjerregaard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Thrombosis and Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131922/
https://www.ncbi.nlm.nih.gov/pubmed/35045569
http://dx.doi.org/10.1182/bloodadvances.2021006484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131922/
https://www.ncbi.nlm.nih.gov/pubmed/35045569
http://dx.doi.org/10.1182/bloodadvances.2021006484

Ejemplares similares